The human immune system has specialized cells called CD4 cytotoxic T lymphocytes (CD4 CTLs), which have been shown to kill ...

People who reach the age of 110 and beyond may owe part of their extraordinary longevity to an immune system that keeps ...

The study found that people with higher CD4 CTL levels had many cellular clones, which could be the reason for their ...

In a recent study posted to the bioRxiv* preprint server, researchers analyzed temporal changes in polyclonal cluster of differentiation 4 (CD4) T-lymphocyte dynamics upon immunization against severe ...

People who reach 110 and beyond appear to have unusually large numbers of rare immune cells capable of killing abnormal cells ...

Single-cell immune profiling found that CD4 cytotoxic T lymphocytes become more abundant around age 100, showing stepwise ...

In the fight against cancer, immunotherapy—which aims to boost the body's natural defenses against cancer—is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes, ...

A panelist discusses how CD4 counts serve as measures of immune system status that typically increase by about 200 in the first year of antiretroviral therapy. Although there can be laboratory ...

People who live to 110 years and older have large populations of a rare type of immune cell that can kill cancer 1, finds a ...

Ascending dose trials of the safety and tolerability of Toca 511, a retroviral replicating vector encoding cytosine deaminase, in patients with recurrent high-grade glioma. Chemotherapy plus ...

Idiopathic CD4 lymphocytopenia (ICL) is a clinical syndrome that is defined by CD4 lymphopenia of less than 300 cells per cubic millimeter in the absence of any primary or acquired cause of ...